Literature DB >> 29608284

A Pseudoisostructural Type II DAH7PS Enzyme from Pseudomonas aeruginosa: Alternative Evolutionary Strategies to Control Shikimate Pathway Flux.

Oliver W Sterritt1,2, Sarah A Kessans1, Geoffrey B Jameson1,2,3, Emily J Parker1,2,4.   

Abstract

The shikimate pathway is responsible for the biosynthesis of key aromatic metabolites in microorganisms and plants. The enzyme 3-deoxy-d- arabino-heptulosonate 7-phosphate synthase (DAH7PS) catalyzes the first step of the pathway and DAH7PSs are classified as either type I or type II. The DAH7PSs from Pseudomonas aeruginosa are of particular interest as open reading frames encoding four putative DAH7PS isoenzymes, two classified as type Iα and two classified as type II, have been identified. Here, the structure of a type II DAH7PS enzyme from P. aeruginosa (PAO1) has been determined at 1.54 Å resolution, in complex with its allosteric inhibitor tryptophan. Structural differences in the extra-barrel elements, when compared to other type II DAH7PS enzymes, directly relate to the formation of a distinct quaternary conformation with consequences for allosteric function and the control of flux to branching pathways. In contrast to the well-characterized Mycobacterium tuberculosis type II DAH7PS, which binds multiple allosteric inhibitors, this PaeDAH7PSPA2843 is observed to be modestly allosterically inhibited by a single aromatic amino acid, tryptophan. In addition, structures in complex with tyrosine or with no allosteric ligand bound were determined. These structures provide new insights into the linkages between the active and allosteric sites. With four putative DAH7PS enzymes, P. aeruginosa appears to have evolved control of shikimate pathway flux at the genetic level, rather than control by multiple allosteric effectors to a single type II DAH7PS, as in M. tuberculosis. Type II DAH7PSs, thus, appear to have a more varied evolutionary trajectory than previously indicated.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29608284     DOI: 10.1021/acs.biochem.8b00082

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Evolving the naturally compromised chorismate mutase from Mycobacterium tuberculosis to top performance.

Authors:  Jūratė Fahrig-Kamarauskaitė; Kathrin Würth-Roderer; Helen V Thorbjørnsrud; Susanne Mailand; Ute Krengel; Peter Kast
Journal:  J Biol Chem       Date:  2020-10-09       Impact factor: 5.157

2.  Point mutations that boost aromatic amino acid production and CO2 assimilation in plants.

Authors:  Ryo Yokoyama; Marcos V V de Oliveira; Yuri Takeda-Kimura; Hirofumi Ishihara; Saleh Alseekh; Stéphanie Arrivault; Vandna Kukshal; Joseph M Jez; Mark Stitt; Alisdair R Fernie; Hiroshi A Maeda
Journal:  Sci Adv       Date:  2022-06-08       Impact factor: 14.957

3.  An Evolutionary Conservation and Druggability Analysis of Enzymes Belonging to the Bacterial Shikimate Pathway.

Authors:  Rok Frlan
Journal:  Antibiotics (Basel)       Date:  2022-05-17

4.  A single amino acid substitution uncouples catalysis and allostery in an essential biosynthetic enzyme in Mycobacterium tuberculosis.

Authors:  Wanting Jiao; Yifei Fan; Nicola J Blackmore; Emily J Parker
Journal:  J Biol Chem       Date:  2020-03-26       Impact factor: 5.157

5.  Isolation and biochemical characterization of a metagenome-derived 3-deoxy-D-arabino-heptulosonate-7-phosphate synthase gene from subtropical marine mangrove wetland sediments.

Authors:  Huaxian Zhao; Hua Gao; Kai Ji; Bing Yan; Quanwen Li; Shuming Mo; Minggang Zheng; Qian Ou; Bo Wu; Nan Li; Chengjian Jiang
Journal:  AMB Express       Date:  2019-02-04       Impact factor: 3.298

Review 6.  Mycobacterium tuberculosis Shikimate Pathway Enzymes as Targets for the Rational Design of Anti-Tuberculosis Drugs.

Authors:  José E S Nunes; Mario A Duque; Talita F de Freitas; Luiza Galina; Luis F S M Timmers; Cristiano V Bizarro; Pablo Machado; Luiz A Basso; Rodrigo G Ducati
Journal:  Molecules       Date:  2020-03-11       Impact factor: 4.411

7.  Evolving the naturally compromised chorismate mutase from Mycobacterium tuberculosis to top performance.

Authors:  Jūrate Fahrig-Kamarauskait; Kathrin Würth-Roderer; Helen V Thorbjørnsrud; Susanne Mailand; Ute Krengel; Peter Kast
Journal:  J Biol Chem       Date:  2020-12-18       Impact factor: 5.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.